SOPHiA GENETICS SA SOPH
6.91 USD -0.20 (-2.81%)
At closeNov 3, 2026, 5:56 PM EST
6.80 -0.11 -1.59%
After hours · Nov 3, 5:56 PM ET
5.92 Day range 7.19
3.83 52-week range 8.98
- YTD
- +47.97%
- 1 year
- +38.20%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 7.00 +1.3% upside
Now 6.91
- Target (low)
- 5.00
- Target (mean)
- 7.00
- Target (high)
- 11.00
Ratings (0m) 6 5 buy · 1 hold · 0 sell
- Strong buy1
- Buy4
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 5
- 2 months ago 5
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.15 | -0.16 – -0.14 | -0.2834 | +47.1% | 17.87M | +4.8% | 2 |
| Next quarter | -0.19 | -0.23 – -0.15 | -0.1381 | -37.6% | 17.25M | +9.3% | 2 |
| Current year | -0.755 | -0.88 – -0.63 | -0.9279 | +18.6% | 65.51M | +5.0% | 2 |
| Next year | -0.62 | -0.67 – -0.57 | -0.755 | +17.9% | 76.52M | +16.8% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 18, 2024 | Craig-Hallum | Initiated | — | Buy |
| Aug 7, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 27, 2024 | Guggenheim | Initiated | — | Buy |
| Mar 6, 2024 | BTIG | Maintained | Buy | Buy |
| Mar 6, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Jan 12, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Nov 29, 2023 | RBC Capital | Initiated | — | Outperform |
| May 10, 2023 | Credit Suisse | Maintained | — | Neutral |
| May 10, 2023 | Morgan Stanley | Maintained | — | Overweight |
| Mar 8, 2023 | Morgan Stanley | Maintained | — | Overweight |
| Jan 3, 2023 | BTIG | Initiated | — | Buy |
| Nov 23, 2022 | Credit Suisse | Initiated | — | Neutral |
| Nov 9, 2022 | Morgan Stanley | Maintained | — | Overweight |
| Aug 10, 2022 | Morgan Stanley | Maintained | — | Overweight |
| May 11, 2022 | Morgan Stanley | Maintained | — | Overweight |
| Mar 16, 2022 | Morgan Stanley | Maintained | — | Overweight |
| Feb 15, 2022 | Morgan Stanley | Maintained | — | Overweight |
| Aug 17, 2021 | Morgan Stanley | Initiated | — | Overweight |
| Aug 17, 2021 | Cowen & Co. | Initiated | — | Outperform |
| Aug 17, 2021 | Credit Suisse | Initiated | — | Outperform |
| Aug 17, 2021 | JP Morgan | Initiated | — | Overweight |